Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets and Tranylcypromine
Determining the interaction of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets and Tranylcypromine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dasabuvir / ombitasvir / paritaprevir / ritonavir
Brand name: Viekira XR, Viekira Pak
Synonyms: Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets, and Dasabuvir
Generic Name: tranylcypromine
Brand name: Parnate
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Tranylcypromine Sulfate
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Tranzarel Gel
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Trastuzumab
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Trastuzumab and Hyaluronidase
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Trastuzumab Injection (Intravenous)
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Trastuzumab Intravenous
- Tranylcypromine-Omeclamox-Pak
- Tranylcypromine-Omega-3 Fatty Acid Capsules
- Tranylcypromine-Omega-3 Fatty Acids
- Tranylcypromine-Omega-3 polyunsaturated fatty acids
- Tranylcypromine-Omega-3-acid ethyl esters
- Tranylcypromine-Omega-3-carboxylic acids